Merrimack Pharmaceuticals Inc
- Raised $77 million (2011)
- 27 clinical trials
- Research grants: $1.1 million
- Founded 2010
Life science companies
Explore 33,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Inotiv
On BioBridgeX
- Raised $275 million (2021)
Pulmotect, Inc.
- Raised $10 million (2024)
- 7 clinical trials, 1 active
- Research grants: $10 million
QurAlis Corp
- Raised $20 million (2025)
- 7 clinical trials, 2 active
- Research grants: $2.2 million
- Founded 2016
Syntis Bio, Inc.
- Raised $25 million (2025)
- 1 clinical trial
- Research grants: $9.8 million
- Founded 2022
Aquestive Therapeutics, Inc.
Nasdaq: AQST
- Raised $9.1 million (2018)
- 9 clinical trials
- 1 FDA-registered drug site
NEUROONE MEDICAL TECHNOLOGIES Corp
Nasdaq: NMTC
- Raised $276,043 (2024)
- 1 clinical trial, 1 active
- FDA-cleared or approved devices
SpeechVive Inc.
- Raised $1.5 million (2020)
- 1 clinical trial
- 1 FDA-registered device site
- Research grants: $2.5 million
Lexicon Pharmaceuticals, Inc.
Nasdaq: LXRX
- Raised $56 million (2026)
- 61 clinical trials, 1 active
LadRx Corp
- Raised $8.2 million (2022)
- 10 clinical trials
- Research grants: $1.3 million
Pearl Diagnostics, Inc.
- Raised $11 million (2026)
- FDA-cleared or approved devices
- Research grants: $8.9 million
- Founded 2022
Spinogenix, Inc.
- Raised $11 million (2026)
- 9 clinical trials, 4 active
- Research grants: $6.6 million
- Founded 2016
Surmodics Inc
- 7 clinical trials, 2 active
- FDA-cleared or approved devices
- Research grants: $19 million
Sonomotion Inc.
- Raised $12 million (2022)
- 2 clinical trials, 1 active
- Research grants: $18 million
Viracta Therapeutics, Inc.
- Raised $29 million (2010)
- 17 clinical trials
- Research grants: $5 million
Iridex Corp
Nasdaq: IRIX
- Raised $10 million (2026)
- FDA-cleared or approved devices
Sonendo, Inc.
- Raised $5 million (2025)
- 3 clinical trials
- FDA-cleared or approved devices
- Founded 2006
Arcutis Biotherapeutics, Inc.
Nasdaq: ARQT
- Raised $94 million (2019)
- 27 clinical trials, 3 active
- Founded 2016
Allyx Therapeutics, Inc.
- Raised $26 million (2026)
- 4 clinical trials, 1 active
- Research grants: $11 million
- Founded 2018
Lung Therapeutics, Inc.
- Raised $10 million (2022)
- Research grants: $2 million
- Founded 2012
Showing 340 of 33,266 companies
Load morePublished company profiles only; counts update daily. Data licences